Christian Rausch
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid Syndrome.
Journal: The New England journal of medicine
Published: March 04, 2026
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients.
Journal: Leukemia
Published: August 15, 2025
Randomized Phase II Study of Brentuximab-Vedotin With High-Dose Chemotherapy in CD30 Positive Lymphoma.
Journal: Hematological oncology
Published: July 29, 2025
Observation of PICALM::MLLT10-rearrangement and coincidental EZH2 mutations in a patient with acute myeloid leukemia: A case report and review of the literature.
Journal: BJC reports
Published: January 20, 2025
Improving risk stratification for 2022 European LeukemiaNet favorable-risk patients with acute myeloid leukemia.
Journal: Innovation (Cambridge (Mass.))
Published: March 25, 2024
Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia - implications for the European LeukemiaNet risk classification.
Journal: Leukemia
Published: July 17, 2023
Friday Leukemia-a Structural Phenomenon.
Journal: Deutsches Arzteblatt international
Published: July 05, 2023
Modeling early treatment response in AML from cell-free tumor DNA.
Journal: iScience
Published: June 16, 2023
Acute Myeloid Leukemia - Update 2022
Journal: Deutsche medizinische Wochenschrift (1946)
Published: August 28, 2022
Combining BeEAM with Brentuximab Vedotin for High-Dose Therapy in CD30 Positive Lymphomas before Autologous Transplantation-A Phase I Study.
Journal: Journal of clinical medicine
Published: July 11, 2022
Last Updated: 09/26/2026